Michel, Martin C.; Charlton, Steven J.
Biased Agonism in Drug Discovery-Is It Too Soon to Choose a Path?MOLECULAR PHARMACOLOGY. Bd. 93. H. 4. 2018 S. 259-265
Closs, Ellen lldicho
Big shoes to fillAMINO ACIDS. Bd. 50. H. 1. 2018 S. 1-1
Steven, Sebastian; Dib, Mobin; Hausding, Michael et al.
CD40L controls obesity-associated vascular inflammation, oxidative stress, and endothelial dysfunction in high fat diet-treated and db/db miceCARDIOVASCULAR RESEARCH. Bd. 114. H. 2. 2018 S. 312-323
Kardos, Peter; Beeh, Kai-Michael; Sent, Ulrike et al.
Characterization of differential patient profiles and therapeutic responses of pharmacy customers for four ambroxol formulationsBMC PHARMACOLOGY & TOXICOLOGY. Bd. 19. 2018
Motulsky, Harvey J.; Michel, Martin C.
Commentary on the BJP's new statistical reporting guidelinesBRITISH JOURNAL OF PHARMACOLOGY. Bd. 175. H. 18. 2018 S. 3636-3637
Paul, Norbert W.; Caplan, Arthur; Shapiro, Michael E. et al.
Determination of Death in Execution by Lethal Injection in ChinaCAMBRIDGE QUARTERLY OF HEALTHCARE ETHICS. Bd. 27. H. 3. 2018 S. 459-466
Bros, Matthias; Youns, Mahmoud; Kollek, Verena et al.
Differentially Tolerized Mouse Antigen Presenting Cells Share a Common miRNA Signature Including Enhanced mmu-miR-223-3p Expression Which Is Sufficient to Imprint a Protolerogenic StateFRONTIERS IN PHARMACOLOGY. Bd. 9. 2018
Amiri, Marjan; Michel, Martin C.
Do review articles boost journal impact factors? A longitudinal analysis for five pharmacology journalsNAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY. Bd. 391. H. 9. 2018 S. 1033-1035
Egea, J.; Fabregat, I.; Frapart, Y. M. et al.
European contribution to the study of ROS: A summary of the findings and prospects for the future from the COST action BM1203 (EU-ROS) (vol 13, pg 94, 2017)REDOX BIOLOGY. Bd. 14. 2018 S. 694-696
Dietrich, Karin; Baumgart, Jan; Eshkind, Leonid et al.
Health-Relevant Phenotypes in the Offspring of Mice Given CAR Activators Prior to PregnancyDRUG METABOLISM AND DISPOSITION. Bd. 46. H. 11. 2018 S. 1827-1835